What does FDA approval actually mean when it comes to peptides? Dr. Jon Kanevsky explains that peptides are not all the same: insulin is one of the most studied peptides in history and helped save countless lives, while newer peptides are still working through clinical trials and long-term testing. He says the clinical trial process is what helps doctors understand safety and efficacy at scale. When the peptide market moves faster than the research, how much confidence should consumers really have?